Edal, Baby Boy .

HRN: 24-67-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/22/2024
03/29/2024
IV
350mg
Q12
MAS
Waiting Final Action 
03/22/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/22/2024
03/29/2024
IV
53mg
Q24
MAS
Waiting Final Action 
03/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/25/2024
04/01/2024
IV
52 Mg LD Then 26mg Maintenance
Q 8 Hours
Meconium Aspiration Syndrome
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: